GLG Inc’s Acorda Therapeutics ACOR Stock Holding History

GLG Inc’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-267	Closed	-$1.06M	–	764
2013 Q2	$1.06M	Buy	+267	New	+$1.1M	0.03%	434

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GLG Inc's ACOR Position: Q3 2013 in Review

GLG Inc sold out of Acorda Therapeutics (ACOR) in Q3 2013, closing a stake of 267 shares — an estimated $1.06M sold.

GLG Inc first reported a position in ACOR in Q2 2013 and held it in 1 quarter. The position peaked at $1.06M in Q2 2013. 153 funds tracked by Wall St. Rank hold ACOR as of Q3 2013.

GLG Inc reported no remaining Acorda Therapeutics position as of Q3 2013 after selling out during the quarter.
GLG Inc sold 267 Acorda Therapeutics shares in Q3 2013, an estimated $1.06M.
GLG Inc first reported a position in Acorda Therapeutics in Q2 2013 and held it in 1 quarter.
GLG Inc's Acorda Therapeutics position peaked at $1.06M in Q2 2013.
153 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2013.

Based on GLG Inc's 13F filing for Q3 2013, filed 14 Nov 2013.